Intriguingly, in this context, animal models of AD overexpressing human ApoA-I were characterized by an improvement of memory deficit and attenuation of Aβ-associated neuroinflammation [35], while ApoA-I deletion exacerbates cerebral Aβ deposition and astrocyte activation in mice [36]. This evidence concerns the gene APOA1 and Alzheimer disease.